Ebola is just one of the lethal pathogens on U.S. lists of high-priority bioterrorism agents that pose a risk to national security. U.S. Army Medical Research Institute of Infectious Diseases scientists conduct research on many of them, whether the pathogens appear on the battlefield or in nature.
A Purdue innovation that could help thwart terrorist attacks from radiological "dirty bombs" and nuclear weapons by tracking potential attacks through smartphones and other devices has been licensed to a Marrero, Louisiana-based startup,
FORSUGO Hi-Cell Inc. The technology also can be retrofitted to identify chemicals and biological contaminants.
The National Geospatial-Intelligence Agency (NGA) recently made available a public-facing website to assist U.S. and international relief efforts in combating the spread of Ebola virus disease. This website provides unprecedented online access to unclassified geospatial intelligence in support of lead federal agencies and partners.
First responders from around the nation gathered in Washington, D.C., for an event, hosted by the Department of Homeland Security Science and Technology Directorate's First Responders Group (FRG), focused on capability gaps and showcased technologies developed based on previous FRG events.
Since 30 September 2014, when the first laboratory-confirmed case of Ebola was diagnosed in the United States, healthcare and emergency responders have rushed to provide the proper protection to their staff. DQE has been there every step of the way to ensure that customers have the protection they need for infection control.
Johns Hopkins Medicine has collaborated with the Centers for Disease Control and Prevention (CDC) to design an interactive Web-based learning program that guides healthcare workers, nurses, and physicians through government-approved protocols to aid clinicians as they provide care to patients who may be at risk of contracting the Ebola virus.
BioFire Defense LLC recently announced that it has received Emergency-Use Authorization by the U.S. Food and Drug Administration for its commercial FilmArray Ebola test (BioThreat-E test) as well as a second Ebola test to be used by laboratories designated by the U.S. Department of Defense.
Researchers at NYU Langone Medical Center will lead a consortium of five institutions, on a $6.5 million contract from the National Institutes of Health, directed at discovery of the fundamental immunology, microbial genetics, protein structure and proteomics of staphylococcus aureus, which is among the most common pathogens that overwhelm the immune system, causing serious skin, soft tissue and life-threatening blood-bourne infections.
Morphix Technologies® is pleased to announce that the Chameleon®, a wearable device that allows hands-free detection of up to 10 different hazards at one time in a variety of operating environments, has been approved by the US SAFETY Act of the Department of Homeland Security as an anti-terrorism technology that will be used to save lives.
To ensure the nation is ready to respond quickly, effectively, and safely in the event of additional Ebola cases in the United States - Secretary Hagel ordered the Northern Command to prepare and train a 30-person expeditionary medical support team that could, if required, provide short-notice assistance to civilian medical professionals in the United States.
